NFKB1 and cancer: The fact that miR-9 is positively regulated by inflammation-induced canonical NF-κB (RelA/65-p50) signaling, taken together with the finding that miR-9 targets NFKB1 (p105/p50), suggests a negative feedback loop mechanism fine tuning the inflammatory response with an impact in cancer.